These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5767 related items for PubMed ID: 3945723

  • 1. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M, Lespinasse F, Malaise EP.
    Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
    [Abstract] [Full Text] [Related]

  • 2. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 3. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 4. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E.
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [Abstract] [Full Text] [Related]

  • 5. Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response.
    Edgren M, Nishidai T, Scott OC, Révész L.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Apr; 47(4):463-74. PubMed ID: 3872859
    [Abstract] [Full Text] [Related]

  • 6. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

  • 7. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ, Gosky D, Zborowska E, Willson JK, Berger NA.
    Cancer Res; 1994 Aug 01; 54(15):4077-83. PubMed ID: 8033140
    [Abstract] [Full Text] [Related]

  • 8. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS.
    Cancer Res; 1988 May 15; 48(10):2764-7. PubMed ID: 3359437
    [Abstract] [Full Text] [Related]

  • 9. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
    Jin YZ, Ding L, Shen ZF, Cai RM, Xu LM, Yang JK, Jin XQ, Lu WQ, Xu JF.
    Chin Med J (Engl); 1992 Aug 15; 105(8):647-50. PubMed ID: 1458967
    [Abstract] [Full Text] [Related]

  • 10. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K, Shrieve DC.
    J Natl Cancer Inst; 1987 Oct 15; 79(4):811-5. PubMed ID: 3477662
    [Abstract] [Full Text] [Related]

  • 11. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A, Smith KA, Soranson JA, Minchinton AI, Middleton RW, Denekamp J.
    Radiother Oncol; 1984 Dec 01; 2(4):325-32. PubMed ID: 6522642
    [Abstract] [Full Text] [Related]

  • 13. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 01; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 14. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Aug 01; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 15. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC, Henderson BW.
    J Natl Cancer Inst; 1986 Aug 01; 77(2):505-10. PubMed ID: 3461211
    [Abstract] [Full Text] [Related]

  • 16. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 01; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 17. Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors.
    Ono K, Komuro C, Nishidai T, Shibamoto Y, Tsutsui K, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Sep 01; 12(9):1661-6. PubMed ID: 3759592
    [Abstract] [Full Text] [Related]

  • 18. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan 01; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 20. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR, Greaves BR, Rasberry U, Barranco SC.
    Cancer Res; 1992 Sep 01; 52(17):4608-12. PubMed ID: 1511428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 289.